Analgesics/Anti-Inflammatory Drugs Preferred Following Implant Placement: A Retrospective Study.

Abstract

In dentistry, pain is a rather inevitable perception that often plagues both the care provider and receiver. Pain, which was described by Rene Descartes in the sixteenth century, has been defined as an unpleasant sensory and emotional experience associated with tissue damage or described in terms of such damage. Various dental procedures also provoke a perception of anxiety that culminates with pain and exaggerates the perception of pain. Hence, adequate pain control and assurance are of utmost importance during and following implant surgery. The aim of the present study was to assess the analgesics and anti-inflammatory drugs preferred following implant placement and also to find an association between gender, age, and various analgesics/anti-inflammatories prescribed following implant surgery. Retrospective data collection was conducted from June 2019 to March 2020 among 200 patients who underwent implant surgery, based on records management system software to analyze the most commonly prescribed analgesics/anti-inflammatory drugs following implant surgery. Among 200 patients the frequency distribution showed that 87% of the patients were prescribed with combination of Aceclofenac (100 mg), Paracetamol (325 mg), and Serratiopeptidase (15 mg), 10% of the patients were prescribed with Paracetamol (650 mg), whereas 3% of the patients were prescribed with Piroxicam (20 mg). The present study showed that combination of Aceclofenac, Paracetamol, and Serratiopeptidase was the commonly prescribed analgesic/anti-inflammatory drug for postoperative pain management following implant placement. Also there was no significant association between gender vs. various analgesics/anti-inflammatory drugs prescribed following implant placement.